Financing & Restructuring Advisory
Greenhill advises corporations, institutions and governments on a wide range of capital structure, restructuring and financing situations. We offer expert advice, extensive transactional experience and comprehensive services unconflicted by capital markets, trading or research activities.
Greenhill's Financing Advisory & Restructuring practice benefits from the experience of some of the longest serving professionals in the industry. Our track record includes pre-emptive recapitalizations, structuring and advice on public offerings, inter-creditor and shareholder negotiations, acquisitions and sales of distressed companies and assets, debt and equity exchange offers and restructuring and a range of other advisory services for a diverse client base. We strive to reach consensual deals that are in the best interests of our clients and we have an established history of brokering transactions in situations with divisive inter-creditor and shareholder issues.
Greenhill advises corporations, institutions and governments on their most critical financing decisions, including large public offerings of equity and debt securities, often for purposes of acquisition financing, rights offerings, strategic alternatives for minority equity positions and multiclass equity structures, private placements and funding alternatives, as well as a wide range of other financing based strategic decisions. Greenhill brings extensive experience negotiating and structuring tailored solutions for our clients with no conflicts from other business activities or product offerings to influence our advice.
Greenhill provides a full range of advisory services to debtors both inside and outside formal bankruptcy. Our goal is to assist debtors by working with all of their stakeholders to implement restructuring plans that balance a pragmatic sharing of value between stakeholders while minimizing corporate uncertainty. We recognize that every situation is unique and that traditional solutions are not always best suited for our clients. Based on our years of experience and wide-variety of previous transactions, we assist debtors with thinking creatively about their options and selecting attributes of different strategic alternatives that can be packaged together into a compelling solution.
Greenhill advises creditors and committees of financially distressed companies both inside and outside formal bankruptcy. Our goal is to help creditors maximize returns from distressed corporate situations and to work with other constituents to achieve that return in a timely manner. We understand that creditors may value the form of consideration and other terms of a restructuring proposal differently, and we work with committees to optimize the returns our clients receive based on their desired outcome.
Greenhill frequently combines the experience of its M&A and restructuring professionals in advising either buyers or sellers of distressed assets and/or companies. Greenhill is able to advise a client throughout the entire process, including identification of targets/buyers, participation in a sales process and court proceedings, if necessary. We look to identify creative tactical or strategic solutions to unlock value in every situation. We recognize that executing M&A in distressed situations requires incremental skills that are not always required within traditional M&A transactions. Some of these skills are working with a highly levered acquiror or target, managing the bankruptcy process, performing a valuation that can withstand court scrutiny and managing inherent conflicts of interest among different constituencies.
Greenhill has dedicated professionals based in London and Sydney focused on financing and restructuring advisory and a strong track record of successful international restructuring transactions. Combining our international footprint with our independence, experience and analytical advice, we provide a high quality advisory service in major restructuring cases around the world.
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
Advised Pixelligent Technologies, a leading manufacturer of nanocrystal material used in consumer electronic devices, on its growth capital raise
Advising Canopy Growth, a leading diversified cannabis company, on the re-organization and consolidation of its U.S. cannabis assets under a new holding company, Canopy USA, and on related investments and debt repurchase transactions
Electro Optic Systems
Advised Electro Optic Systems, an Australian founded and listed aerospace and defence company, on agreeing financing terms with its largest shareholder, Washington H. Soul Pattinson
Advising brsk, a UK-based alternative network broadband provider, on its first debt-raise of £178m from Ares Management, a leading global alternative investment manager